Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06098287 · ClinicalTrials.gov registry record · NA
Residential Ventilation Systems and Filtration for Asthma Control in Adults
A NA study of Asthma and Pollution; Exposure, sponsored by Illinois Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 1
- Study location
NCT06098287: Completed NA study of Asthma and Pollution; Exposure, sponsored by Illinois Institute of Technology.
NCT06098287 is a NA study of Asthma and Pollution; Exposure that has completed, run by Illinois Institute of Technology. The registered enrollment target is 51 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06098287, a NA study of Asthma and Pollution; Exposure, has completed, sponsored by Illinois Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study was to investigate the effectiveness of three common approaches to upgrading residential mechanical ventilation systems in existing homes for improving asthma-related health outcomes, reducing indoor pollutants of both indoor and outdoor origin, and maintaining adequate environmental conditions and ventilation rates in a cohort of adult asthmatics in existing homes in Chicago, IL.
Primary Outcome
Asthma Control Test (ACT) is a 5-item clinically validated survey, which is designed to measure the multi-dimensional nature of asthma control, including asthma symptoms, utilization of rescue medications, and the impact of asthma on daily functioning. The ACT score ranges from 5 ("poor control of asthma") to 25 ("complete control of asthma")
Conditions Studied
Interventions
- DEVICE Residential mechanical ventilation system (Exhaust)
- DEVICE Residential mechanical ventilation system (CFIS) and air filtration upgrades
- DEVICE Residential mechanical ventilation system (ERV) and air filtration upgrades
Study Locations (1)
Illinois
- Illinois Institute of Technology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2020-11-30 |
| Phase | NA |
What the finished NCT06098287 record still lists
NCT06098287 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 3 interventions - of which Residential mechanical ventilation system (Exhaust) is the first listed.
NCT06098287 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06098287 about?
NCT06098287 is a clinical study titled "Residential Ventilation Systems and Filtration for Asthma Control in Adults". The goal of this study was to investigate the effectiveness of three common approaches to upgrading residential mechanical ventilation systems in existing homes for improving asthma-related health outcomes, reducing indoor pollutants of both indoor and outdoor origin, and maintaining adequate enviro...
What is the current status of trial NCT06098287?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2017-01-01. Estimated completion is 2020-11-30.
What conditions does trial NCT06098287 study?
This clinical trial studies the following conditions: Asthma, Pollution; Exposure.
What interventions are being tested in trial NCT06098287?
The interventions under investigation include: Residential mechanical ventilation system (Exhaust) (DEVICE), Residential mechanical ventilation system (CFIS) and air filtration upgrades (DEVICE), Residential mechanical ventilation system (ERV) and air filtration upgrades (DEVICE).
Who is sponsoring clinical trial NCT06098287?
This trial is sponsored by Illinois Institute of Technology, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06098287 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06098287's enrollment target sits among peer trials
51 262nd of 374 higher than 113 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI